Page 64 - Hormel Report 2023

64 | THE HORMEL INSTITUTE // Paul, S., Kaplan, M. H., Khanna, D., McCourt,
P. M., Saha, A. K., Tsou, P. S., Anand, M., Radecki, A., Mourad, M., Sawalha, A. H., Markovitz, D. M., & Contreras-Galindo, R. (2022). Centromere defects, chromosome instability, and cGAS-STING activation in systemic sclerosis. Nature Communications, 13(1), 16.
Mladek, A. C., Yan, H. H., Tian, S. L., Decker, P. A., Burgenske, D. M., Bakken, K., Hu,
Z., He, L. H., Connors, M. A., Carlson, B.
L., Wilson, J., Bommi-Reddy, A., Conery,
A., Eckel-Passow, J. E., Sarkaria, J. N., & Kitange, G. J. (2022). RBBP4-p300 axis modulates expression of genes essential for cell survival and is a potential target for therapy in glioblastoma. Neuro-Oncology, 24(8), 1261-1272.
Zhang, L., Nesvick, C. L., Day, C. A., Choi, J., Lu, V. M., Peterson, T., Power, E. A., Anderson, J. B., Hamdan, F. H., Decker, P. A., Simons, R., Welby, J. P., Siada, R., Ge, J. Z., Kaptzan, T., Johnsen, S. A., Hinchcliffe, E. H., & Daniels, D. J. (2022). STAT3 is a biologically relevant therapeutic target in H3K27M-mutant diffuse midline glioma. Neuro-Oncology, 24(10), 1700-1711.
Sperger, J. M., Helzer, K. T., Stahlfeld, C. N., Jiang, D., Singh, A., Kaufmann, K. R., Niles, D. J., Heninger, E., Rydzewski, N. R., Wang, L., Wang, L., Yang, R., Ren, Y., et. al. (2023). Expression and therapeutic targeting of trop-2 in treatment-resistant prostate cancer. Clinical cancer research, 29(12), 2324-2335.
Serra-Cardona, A., Duan, S., Yu, C., & Zhang, Z. (2022). H3k4me3 recognition by the compass complex facilitates the restoration of this histone mark following DNA replication. Science Advances, 8(18).
Grimm, C., Liu, B., Flegler, V. J., & Kim, J. J. (2023). Developing protein structure figures. Trends in Biochemical Sciences, 48(3), 199-202.
Bu, F., Kompaniiets, D., & Liu, B. (2023). How to compile different types of structural visualizations in one panel. Trends in Biochemical Sciences, 48(3), 303-304.
UNIVERSITY OF MINNESOTA
Le, L. T. M., Thompson, J. R., Dehghani- Ghahnaviyeh, S., Pant, S., Dang, P. X., French, J. B., Kanikeyo, T., Tajkhorshid, E., & Alam, A. (2023). Cryo-EM structures of human ABCA7 provide insights into its phospholipid translocation mechanisms. EMBO Journal, 42(3), 14.
Alam, A., & Locher, K. P. (2023). Structure and Mechanism of Human ABC Transporters. Annual Review of Biophysics, 52, 275-300.
Anderson, K. G., Braun, D. A., Buqué, A., Gitto, S. B., Guerriero, J. L., Horton, B., Keenan, B. P., Kim, T. S., Overacre-Delgoffe, A., Ruella, M., Triplett, T. A., Veeranki, O., Verma, V.,
& Zhang, F. (2023). Leveraging immune resistance archetypes in solid cancer to inform next-generation anticancer therapies. Journal for ImmunoTherapy of Cancer, 11(6).
Fortuna, K. L., Lebby, S., Geiger, P., Johnson, D., MacDonald, S., Chefetz, I., et. al. (2023). Lived experience-led research agenda
to address early death in people with a diagnosis of a serious mental illness a consensus statement. JAMA Network Open, 6(5), E2315479.
Sun, L., Wang, Y., Wang, X., Navarro- Corcuera, A., Ilyas, S., Jalan-Sakrikar, N., Gan, C., Tu, X., Shi, Y., Tu, K., Liu, Q., Lou, Z., Dong, H., Sharpe, A. H., Shah, V. H., & Kang, N. (2022). PD-L1 promotes myofibroblastic activation of hepatic stellate cells by distinct mechanisms selective for TGF-β receptor I versus II. Cell Reports, 38(6), 110349.
Phoenix, K. N., Yue, Z. C., Yue, L. X., Cronin, C. G., Liang, B. T., Hoeppner, L. H., & Claffey, K. P. (2022). PLC beta 2 Promotes VEGF-Induced Vascular Permeability. Arteriosclerosis Thrombosis and Vascular Biology, 42(10), 1229-1241.
Li, Z., Tan, Y., Li, X., Quan, J., Bode, A. M., Cao, Y., & Luo, X. (2022). Dhrs2 inhibits cell growth and metastasis in ovarian cancer by downregulation of chkα to disrupt choline metabolism. Cell Death and Disease, 13(10).
PUBLICATIONS
Wang, Z., Yan, H., Boysen, J. C., Secreto, C. R., Tschumper, R. C., Ali, D., Guo, Q., Zhong, J., Zhou, J., Gan, H., Yu, C., Jelinek, D. F., Slager, S. L., Parikh, S. A., Braggio, E., & Kay, N. E. (2022). B cell receptor signaling drives apobec3 expression via direct enhancer regulation in chronic lymphocytic leukemia b cells. Blood Cancer Journal, 12(7).
Chen, L. L., Wu, C. T., Lin, C. H., Dai, R. J., Liu, C. Y., Clarke, R., Yu, G. Q., Van Eyk, J.
E., Herrington, D. M., & Wang, Y. (2022). swCAM: estimation of subtype-specific expressions in individual samples with unsupervised sample-wise deconvolution. Bioinformatics, 38(5), 1403-1410.
Roh, E., Kim, J. E., Zhang, T., Shin, S. H., Kim, B. G., Li, J., Ma, X., Lee, K. W., & Dong, Z. (2023). Orobol, 3′-hydroxy-genistein, suppresses the development and regrowth of cutaneous scc. Biochemical Pharmacology, 209.
Day, C. A., Hinchcliffe, E. H., & Robinson, J. P. (2022). H3K27me3 in Diffuse Midline Glioma and Epithelial Ovarian Cancer: Opposing Epigenetic Changes Leading to the Same Poor Outcomes. Cells, 11(21), 19.
Krotova, K., Kuoch, H., Caine, C., & Aslanidi, G. (2023). Tumor antigen-loaded AAV vaccine drives protective immunity in a melanoma animal model. Molecular Therapy - Methods and Clinical Development, 28, 301-311.
Alam, S. K., Wang, L., Zhu, Z., & Hoeppner, L. H. (2023). IKKα promotes lung adenocarcinoma growth through ERK signaling activation via DARPP-32- mediated inhibition of PP1 activity. npj Precision Oncology, 7(1), 16.
Wang, Q., Bode, A. M., & Zhang, T. (2023).
Targeting CDK1 in cancer: mechanisms and implications. npj Precision Oncology, 7(1), 58.
Hai, R., Yang, D., Zheng, F., Wang, W., Han, X., Bode, A. M., & Luo, X. (2022). The emerging roles of hdacs and their therapeutic implications in cancer. European Journal of Pharmacology, 931.
Pant, K., Richard, S., Peixoto, E., Yin, J., Seelig, D. M., Carotenuto, P., Salati, M., Franco, B., Roberts, L. R., & Gradilone,
S. A. (2023). The nampt inhibitor fk866 in combination with cisplatin reduces cholangiocarcinoma cells growth. Cells, 12(5), 12.
Andrade, F. D. O., Jin, L., Clarke, R., Wood,
I., Dutton, M., Anjorin, C., Rubin, G., Gao,
A., Sengupta, S., FitzGerald, K., & Hilakivi- Clarke, L. (2023). Social Isolation Activates Dormant Mammary Tumors, and Modifies Inflammatory and Mitochondrial Metabolic Pathways in the Rat Mammary Gland. Cells, 12(6), 961.
Yang, F., Hilakivi-Clarke, L., Shaha, A., Wang, Y., Wang, X., Deng, Y., Lai, J., & Kang, N. (2023). Metabolic reprogramming and
its clinical implication for liver cancer. Hepatology.
Onal, T., Ozgul-Onal, M., & Chefetz, I.
(2023). Mixed lineage kinase domain-like pseudokinase: Conventional (necroptosis) and unconventional (necroptosis- independent) functions and features. Advances in Protein Chemistry and Structural Biology, 134, 225-243.
Peixoto, E., Khan, A., Lewis, Z. A., Contreras-Galindo, R., & Czaja, W. (2022). The Chromatin Remodeler HELLS: A New Regulator in DNA Repair, Genome Maintenance, and Cancer. International Journal of Molecular Sciences, 23(16), 12.
Chesnokov, M. S., Yadav, A., & Chefetz,
I. (2022). Optimized transcriptional signature for evaluation of mek/erk pathway baseline activity and long-term modulations in ovarian cancer. International Journal of Molecular Sciences, 23(21).
Ruiz, V. H., Encinas-Basurto, D., Sun, B., Eedara, B. B., Roh, E., Alarcon, N. O., Curiel- Lewandrowski, C., Bode, A. M., & Mansour, H. M. (2023). Innovative rocuronium bromide topical formulation for targeted skin drug delivery: Design, comprehensive characterization, in vitro 2d/3d human cell culture and permeation. International Journal of Molecular Sciences, 24(10).